North East, MD, United States of America

Mark Gordon Mortenson

This inventor holds 33 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Nanoparticle Manufacturing. Top assignees: Grintellectual Reserve, LLC, Lanxide Technology Company, LP, Clene Nanomedicine, Inc.. Active years: 1989-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Gordon Mortenson. Retrieved from https://idiyas.com/inventor/mark-gordon-mortenson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 10)

% Patents Active = 72.7

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 144(Granted Patents)

Company Filing History:

14 out of 20

Grintellectual Reserve, LLC

patents

8 out of 312

Lanxide Technology Company, LP

patents

5 out of 5

Clene Nanomedicine, Inc.

patents

4. 1 out of 1

Ciene Nanomedicine, Inc.

patent

5. 1 out of 1

Clene Nanomedicine, Inc, a Nevada Corporation

patent

6. 1 out of 1

Gr Intellectual Reserve, LLC, a Nevada LLC

patent

7. 3 out of 834,453

Other

patents

Years Active: 1989-2025

Loading Chart...

Areas of Expertise:

Nanoparticles

Electrochemical Processes

Gold-Based Nanocrystals

Crystallization Control

Fuel Cell Reactions

Data Storage Devices

Solar Cells

Metal Matrix Composites

Continuous Treatment Methods

Colloids

Macrocomposite Bodies

Apparatuses

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415218 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2025-09-16),

2. 11007573 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2021-05-18),

3. 11000042 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2021-05-11),

4. 10980832 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2021-04-20),

5. 10449217 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2019-10-22),

6. 10441608 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2019-10-15),

7. 10092007 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2018-10-09),

8. 10035192 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g.,nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2018-07-31),

9. 9743672 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2017-08-29),

10. 9603870 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2017-03-28),

11. 9387452 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2016-07-12),

12. 9387225 - Gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same (2016-07-12),

13. 9067263 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2015-06-30),

14. 8734535 - Methods for controlling crystal growth, crystallization, structures and phases in materials and systems (2014-05-27),

15. 8617360 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2013-12-31),

Title: Innovator Spotlight: Mark Gordon Mortenson

Introduction:

Mark Gordon Mortenson is a prolific inventor based in North East, MD, with an impressive track record of 32 patents. His innovative work has significantly contributed to the field of nanoparticle manufacturing and liquid treatment processes.

Latest Patents:

One of Mortenson's recent patents involves continuous, semicontinuous, and batch methods for treating liquids and manufacturing nanoparticles in liquids. This invention introduces novel techniques and devices for creating nanoparticles, microparticles, and nanoparticle/liquid solutions. By utilizing adjustable plasmas and electrochemical processing techniques, Mortenson's process results in the formation of unique nanoparticles with diverse compositions and properties.

Career Highlights:

Mortenson has made substantial contributions to companies like Grintellectual Reserve, LLC, and Lanxide Technology Company, LP. His forward-thinking approaches to innovation have propelled these organizations towards cutting-edge advancements in the field.

Collaborations:

Throughout his career, Mortenson has collaborated with esteemed professionals such as David Andrew Bryce and David Kyle Pierce. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to groundbreaking inventions and patents in the industry.

Conclusion:

Mark Gordon Mortenson's dedication to pushing the boundaries of nanoparticle manufacturing and liquid treatment processes is evident in his extensive patent portfolio. His collaborative spirit and inventive thinking continue to inspire new advancements in the field, solidifying his legacy as a trailblazer in innovation.

Profile summary based on public USPTO records.